These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39376163)

  • 21. Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 - 2016: Using population-based administrative data to support a geographic based near real-time tool.
    Shen AK; Warnock R; Brereton S; McKean S; Wernecke M; Chu S; Kelman JA
    Hum Vaccin Immunother; 2018; 14(8):1848-1852. PubMed ID: 29641277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ; Santibanez TA; Williams WW; Zhang J; Ding H; Bryan L; O'Halloran A; Greby SM; Bridges CB; Graitcer SB; Kennedy ED; Lindley MC; Ahluwalia IB; LaVail K; Pabst LJ; Harris L; Vogt T; Town M; Singleton JA;
    MMWR Surveill Summ; 2013 Oct; 62(4):1-28. PubMed ID: 24157710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccination coverage in the 2004/05, 2005/06, and 2006/07 seasons: a secondary data analysis based on billing data of the German associations of statutory health insurance physicians.
    Reuss AM; Walter D; Feig M; Kappelmayer L; Buchholz U; Eckmanns T; Poggensee G
    Dtsch Arztebl Int; 2010 Dec; 107(48):845-50. PubMed ID: 21173931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
    Blank PR; Schwenkglenks M; Szucs TD
    J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity-United States, 2009-10 Through 2021-22 Influenza Seasons.
    Black CL; O'Halloran A; Hung MC; Srivastav A; Lu PJ; Garg S; Jhung M; Fry A; Jatlaoui TC; Davenport E; Burns E;
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1366-1373. PubMed ID: 36302226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital Gamification Tool (Let's Control Flu) to Increase Vaccination Coverage Rates: Proposal for Algorithm Development.
    Lopes H; Baptista-Leite R; Hermenegildo C; Atun R
    JMIR Res Protoc; 2024 Sep; 13():e55613. PubMed ID: 39255031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Fiebelkorn AP
    MMWR Surveill Summ; 2017 May; 66(11):1-28. PubMed ID: 28472027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
    Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018.
    Huebbe B; Mocek A; Manz KC; Vivirito A; Bayer LJ; Norris R; Schiffner-Rohe J; von Eiff C; Lade C
    J Med Econ; 2024; 27(1):1063-1075. PubMed ID: 39105626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate.
    Preaud E; Durand L; Macabeo B; Farkas N; Sloesen B; Palache A; Shupo F; Samson SI;
    BMC Public Health; 2014 Aug; 14():813. PubMed ID: 25103091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine uptake among older adults in Brazil: Socioeconomic equality and the role of preventive policies and public services.
    Sato APS; Antunes JLF; Lima-Costa MFF; Bof de Andrade F
    J Infect Public Health; 2020 Feb; 13(2):211-215. PubMed ID: 31431425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.
    Blank PR; Schwenkglenks M; Szucs TD
    Infection; 2009 Oct; 37(5):390-400. PubMed ID: 19768382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    Benjamin-Chung J; Arnold BF; Kennedy CJ; Mishra K; Pokpongkiat N; Nguyen A; Jilek W; Holbrook K; Pan E; Kirley PD; Libby T; Hubbard AE; Reingold A; Colford JM
    PLoS Med; 2020 Aug; 17(8):e1003238. PubMed ID: 32810149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
    Jackson ML; Phillips CH; Benoit J; Jackson LA; Gaglani M; Murthy K; McLean HQ; Belongia EA; Malosh R; Zimmerman R; Flannery B
    Vaccine; 2018 Jan; 36(4):467-472. PubMed ID: 29249545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of influenza vaccination among high-risk Black and White adults.
    Crouse Quinn S; Jamison AM; Freimuth VS; An J; Hancock GR
    Vaccine; 2017 Dec; 35(51):7154-7159. PubMed ID: 29126805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating averted illnesses from influenza vaccination for children and pregnant women - El Salvador, Panama, and Peru, 2011-2018.
    Chard AN; Machingaidze C; Loayza S; Gharpure R; Nogareda F; González R; Domínguez R; Tinoco YO; Dawood FS; Carreon JD; Lafond KE; Jara J; Azziz-Baumgartner E; Cozza V; Couto P; Rolfes MA; Tempia S
    Vaccine; 2024 Oct; 42 Suppl 4(Suppl 4):125861. PubMed ID: 38584055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    Mena G; Casas I; Casañ C; Auñón M; Matas L; Mòdol JM; Esteve M
    PLoS One; 2021; 16(12):e0260397. PubMed ID: 34855801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.